相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity
M. Ibernon et al.
CLINICAL NEPHROLOGY (2011)
Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement
C. Iatrou et al.
CLINICAL NEPHROLOGY (2011)
Mycophenolate Mofetil for Induction and Maintenance of Remission in Microscopic Polyangiitis with Mild to Moderate Renal Involvement-A Prospective, Open-Label Pilot Trial
Francisco Silva et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Controlled Trial
Thomas F. Hiemstra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Kirsten de Groot et al.
ANNALS OF INTERNAL MEDICINE (2009)
Challenges in the management of microscopic polyangiitis: past, present and future
David Jayne
CURRENT OPINION IN RHEUMATOLOGY (2008)
Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients
Min Chen et al.
MEDICINE (2008)
Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement
Weixin Hu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Randomized trial of plasma exchange or high-dosage Methylprednisolone as adjunctive therapy for severe renal vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide
Patricia M. Stassen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: The first population-based, retrospective, epidemiologic survey in Japan
Shouichi Fujimoto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis
M Koukoulaki et al.
NEPHRON CLINICAL PRACTICE (2006)
A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis
MS Joy et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre
M Chen et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis
CA Langford et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors:: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients
L Guillevin et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups
HA Hauer et al.
KIDNEY INTERNATIONAL (2002)
The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review
K de Groot et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
分享论文
